CANCER LETTERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2023-11-08 gwchen15 来自上海

大修后Required Reviews Completed已经2周了，怎么还没消息？

90 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2025-09-25 ms8000002977722174 来自上海

去年3月10日投稿，3天就收到初审通过邮件。
3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱）
一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。
因补做实验申请延期1个月，5月24日提交返修稿。
二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。

35 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2024-12-16 dsaef 来自俄克拉何马

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！

97 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2025-01-03 121f2f52m05(暂无昵称) 来自上海

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：临床肿瘤
经验分享：2024.4.9：submitted;
2024.10.6: Require reviewers completed;
2024.11.07:Major revision;
2024.12.16:Revision Submitted to Journal;
2024.12.17:with editor;
2024.12.18:under review;
2024.12.27:Required Reviews Completed;
2024.12.30:Decision in process;
2025.01.01:Accept;
2025.01.02:proof

137 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2025-09-01 ms7000002977722172 来自上海

5月2号投稿，当天状态显示 “submitted”。
5月4 进入 “with editor” 状态。
5月7稿件送审，变为 “under review”。
差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。
我花了近 1个月完成修改
6月25重新提交修订稿。
次日状态更新为 “with editor”
6月26再次送审。
仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改
7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。

58 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2024-10-04 ms9000001717949106 来自北京

我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~
Submissions Waiting for Author's Approval (0)

122 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2025-03-14 ms9000001817929142 来自北京

偏重的研究方向：肿瘤
经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？

78 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2024-10-24 gkswnd 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;耐药机制
经验分享：05.22 Submitted to Journal
05.22 With editor
05.24 Under review
06.14 Required reviews completed
06.18 Major revision
两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。
09.17 Revision Submitted to Journal
09.20 Under review
09.27 Required reviews completed
10.01 Minor revision
二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。
10.07 Revision Submitted to Journal
10.08 With Editor
10.13 Under review
10.15 Required reviews completed
三审的节奏明显慢了，不知道啥时候给信，焦虑。

125 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2024-09-02 ms4000000067455992 来自重庆

接accept，接accept

151 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167460, encodeId=49a2216e460c5, content=大修后Required Reviews Completed已经2周了，怎么还没消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6af2836723, createdName=gwchen15, createdTime=Wed Nov 08 20:48:56 CST 2023, time=2023-11-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2282719, encodeId=c4c32282e192c, content=去年3月10日投稿，3天就收到初审通过邮件。 3月15日稿件进入 under review 状态（官网显示的6天初审周期确实靠谱） 一审送审40 天，4月24 日收到大修意见2 位审稿人提问极细致，不仅指出实验设计的细节漏洞，还要求补充动物模型验证关键机制，编辑特别标注需在 30 天内修回。 因补做实验申请延期1个月，5月24日提交返修稿。 二审节奏明显加快，仅用12天就返回小修意见，主要聚焦数据图表规范和讨论部分的逻辑优化。5 月 36 日完成修改提交，6月8日收到接收通知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Thu Sep 25 23:46:41 CST 2025, time=2025-09-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242784, encodeId=99fe2242e845e, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了1篇，前后修回了6轮，太不容易了，终于接收了，明年应该就10分以上了，希望能再接再厉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/09/3c521de7fe7837936c39b47e71d5b9b4.jpg, createdBy=a37f2090445, createdName=dsaef, createdTime=Mon Dec 16 08:20:07 CST 2024, time=2024-12-16, status=1, ipAttribution=俄克拉何马), GetPortalCommentsPageByObjectIdResponse(id=2246357, encodeId=3a94224635ede, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：临床肿瘤 经验分享：2024.4.9：submitted; 2024.10.6: Require reviewers completed; 2024.11.07:Major revision; 2024.12.16:Revision Submitted to Journal; 2024.12.17:with editor; 2024.12.18:under review; 2024.12.27:Required Reviews Completed; 2024.12.30:Decision in process; 2025.01.01:Accept; 2025.01.02:proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=134c2294591, createdName=121f2f52m05(暂无昵称), createdTime=Fri Jan 03 14:11:31 CST 2025, time=2025-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2279638, encodeId=0b6122e963818, content=5月2号投稿，当天状态显示 “submitted”。 5月4 进入 “with editor” 状态。 5月7稿件送审，变为 “under review”。 差不多等了1个半月后，5月24，“Required Reviews Completed”，收到审稿意见， Major revision。 我花了近 1个月完成修改 6月25重新提交修订稿。 次日状态更新为 “with editor” 6月26再次送审。 仅1周后7月3“Required Reviews Completed”，编辑给出 Minor revision。我迅速修改 7月12提交，隔天便显示 “Accept”，后续很快进入 proof 环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722172, createdTime=Mon Sep 01 22:45:45 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2229206, encodeId=761f222920678, content=我提交后登录通讯作者账号，看不到我提交的文章是什么情况呀？求求救救孩子吧~~ Submissions Waiting for Author's Approval (0), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbf9484434, createdName=ms9000001717949106, createdTime=Fri Oct 04 15:19:54 CST 2024, time=2024-10-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256114, encodeId=f72d2256114ff, content=偏重的研究方向：肿瘤 经验分享：求问under review会显示具体送了多少审稿人吗？在决策前一直显示under review吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc889232803, createdName=ms9000001817929142, createdTime=Fri Mar 14 18:55:18 CST 2025, time=2025-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232848, encodeId=751422328484e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;耐药机制 经验分享：05.22 Submitted to Journal 05.22 With editor 05.24 Under review 06.14 Required reviews completed 06.18 Major revision 两个审稿人一审给了一个月时间。第一个大小20多个意见，很细节都好解决。第二个一个意见，要求换个动物模型验证。为了满足第二个审稿人的意见修改时间延长了两个月。 09.17 Revision Submitted to Journal 09.20 Under review 09.27 Required reviews completed 10.01 Minor revision 二审给了7天时间。第一个审稿人认为几乎适合发表，基于revision note的内容又提了三个意见，加点文字说明和补充数据。第二个审稿人认为可以接收发表。 10.07 Revision Submitted to Journal 10.08 With Editor 10.13 Under review 10.15 Required reviews completed 三审的节奏明显慢了，不知道啥时候给信，焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=779a5593142, createdName=gkswnd, createdTime=Thu Oct 24 12:21:27 CST 2024, time=2024-10-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2223722, encodeId=e4d62223e22c0, content=接accept，接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Mon Sep 02 18:01:03 CST 2024, time=2024-09-02, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203640, encodeId=ce3e2203640b4, content=第二次投cancer letters，记录时间 05/05/2024 投稿 05/07/2024 With editor 05/08/2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Thu May 09 11:25:45 CST 2024, time=2024-05-09, status=1, ipAttribution=上海)]

2024-05-09 ms3000000772221561 来自上海

第二次投cancer letters，记录时间
05/05/2024 投稿
05/07/2024 With editor
05/08/2024 Under Review

195 4 举报

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务